# Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

> **NCT04553471** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 70 (actual)

## Conditions studied

- Sarcoma
- Thoracic Cancer
- Abdominal Cancer
- Pelvic Cancer

## Interventions

- **RADIATION:** Stereotactic body radiotherapy
- **PROCEDURE:** Research blood draw

## Key facts

- **NCT ID:** NCT04553471
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2022-09-30
- **Final completion:** 2023-05-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04553471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04553471, "Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04553471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
